Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|5|6|549-556

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.5, Iss.6, 2005-12, pp. : 549-556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 431-432

Bentham Science Publishers

Access to resources Recommend Favorite

ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 471-479

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid Drugs and Enhancement of Endocannabinoid Responses: Strategies for a Wide Array of Disease States

By  

Current Molecular Medicine, Vol. 6, Iss. 6, 2006-09 ,pp. : 677-684

Bentham Science Publishers

Access to resources Recommend Favorite

H2-Receptor Antagonists: Development and Application

By Feldman Saul  

Allergy and Asthma Proceedings, Vol. 7, Iss. 4, 1986-07 ,pp. : 362-366

OceanSide Publications, Inc

Access to resources Recommend Favorite

Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling

By Hoshino Makoto  

Clinical Reviews in Allergy and Immunology, Vol. 27, Iss. 1, 2004-02 ,pp. : 59-64

Humana Press, Inc

Access to resources Recommend Favorite